Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.
Please log in, or sign up for a new account to continue reading.
Thank you for reading! We hope that you continue to enjoy our free content.
Welcome! We hope that you enjoy our free content.
Thank you for reading! On your next view you will be asked to log in to your subscriber account or create an account and subscribepurchase a subscription to continue reading.
Thank you for reading! On your next view you will be asked to log in to your subscriber account or create an account and subscribepurchase a subscription to continue reading.
Thank you for signing in! We hope that you continue to enjoy our free content.
Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.
Your current subscription does not provide access to this content.
✓ Print Delivery by Direct Mail to your home or business!
✓ Unlimited desktop and mobile access
✓ Access to the Sunnyside Sun e-Edition
✓ Cancel anytime
| Rate | Price | Duration |
|---|---|---|
| One year, Yakima & Benton County | $52.00 | for 365 days |
| Six months, Yakima & Benton County | $30.00 | for 180 days |
| One year, out of county | $62.00 | for 365 days |
| Six months, out of county | $45.00 | for 180 days |
✓ Unlimited desktop and mobile access
✓ Access to the Sunnyside Sun e-Edition
✓ Cancel anytime
| Rate | Price | Duration |
|---|---|---|
| One year | $40.00 | for 365 days |
| Six months | $25.00 | for 180 days |
| Three months | $20.00 | for 90 days |
| One month | $10.00 | for 30 days |
Current print subscribers receive complimentary access to our digital e-edition and online content. Enjoying our latest issue is as easy as signing up for a free user account and connecting with your Account Number and Last Name!
Your Account Number can be found on your renewal notice.
Please disable your ad blocker, whitelist our site, or purchase a subscription
A pharmaceutical company has recalled a blood pressure medication due to a potential cancer risk, the FDA announced this week.
Aurobindo Pharma USA, Inc. announced a voluntary recall of two lots of quinapril and hydrochlorothiazide tablets which are often prescribed for the treatment of hypertension to lower blood pressure. The recall is due to higher levels of nitrosamine present in the tablets.
Low levels of nitrosamine are commonly found in water and foods, including cured and grilled meats, dairy products and vegetables. Exposure to higher levels has been linked with an elevated risk of cancer, according to the FDA.
According to the FDA, the tablets are “pink colored, scored, round shaped, biconvex, film-coated tablets, debossed with ‘D’ on scored side and ‘19’on other side.”
"Patients should contact their doctor or health care provider about whether to continue taking their medication, or whether to consider an alternative treatment prior to returning their medication," according to the FDA’s website.
To date, there have not been any reports of adverse events related to this recall.
Consumers with questions about the recall can call 1-866-850-2876 or email pvg@aurobindousa.com.
The recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Sorry, there are no recent results for popular commented articles.
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Please disable your ad blocker, whitelist our site, or purchase a subscription
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.